JP5202953B2 - 心臓幹細胞 - Google Patents

心臓幹細胞 Download PDF

Info

Publication number
JP5202953B2
JP5202953B2 JP2007540148A JP2007540148A JP5202953B2 JP 5202953 B2 JP5202953 B2 JP 5202953B2 JP 2007540148 A JP2007540148 A JP 2007540148A JP 2007540148 A JP2007540148 A JP 2007540148A JP 5202953 B2 JP5202953 B2 JP 5202953B2
Authority
JP
Japan
Prior art keywords
cells
heart
tissue
cdc
cardiosphere
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP2007540148A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008518730A5 (cg-RX-API-DMAC7.html
JP2008518730A (ja
Inventor
エドアルド マーバン
マリア ローゼル アブラハム
レイチェル アール. スミス
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Johns Hopkins University
Original Assignee
Johns Hopkins University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johns Hopkins University filed Critical Johns Hopkins University
Publication of JP2008518730A publication Critical patent/JP2008518730A/ja
Publication of JP2008518730A5 publication Critical patent/JP2008518730A5/ja
Application granted granted Critical
Publication of JP5202953B2 publication Critical patent/JP5202953B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0657—Cardiomyocytes; Heart cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/44—Thiols, e.g. mercaptoethanol
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/11—Epidermal growth factor [EGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/175—Cardiotrophin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/998—Proteins not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/30—Synthetic polymers
    • C12N2533/32—Polylysine, polyornithine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins
    • C12N2533/52—Fibronectin; Laminin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Endoscopes (AREA)
JP2007540148A 2004-11-08 2005-11-08 心臓幹細胞 Expired - Lifetime JP5202953B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US62569504P 2004-11-08 2004-11-08
US60/625,695 2004-11-08
PCT/US2005/040359 WO2006052925A2 (en) 2004-11-08 2005-11-08 Cardiac stem cells

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012229481A Division JP2013046780A (ja) 2004-11-08 2012-10-17 心臓幹細胞

Publications (3)

Publication Number Publication Date
JP2008518730A JP2008518730A (ja) 2008-06-05
JP2008518730A5 JP2008518730A5 (cg-RX-API-DMAC7.html) 2008-12-25
JP5202953B2 true JP5202953B2 (ja) 2013-06-05

Family

ID=36337122

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2007540148A Expired - Lifetime JP5202953B2 (ja) 2004-11-08 2005-11-08 心臓幹細胞
JP2012229481A Pending JP2013046780A (ja) 2004-11-08 2012-10-17 心臓幹細胞
JP2015112139A Expired - Lifetime JP6076402B2 (ja) 2004-11-08 2015-06-02 心臓幹細胞

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2012229481A Pending JP2013046780A (ja) 2004-11-08 2012-10-17 心臓幹細胞
JP2015112139A Expired - Lifetime JP6076402B2 (ja) 2004-11-08 2015-06-02 心臓幹細胞

Country Status (7)

Country Link
US (3) US20080267921A1 (cg-RX-API-DMAC7.html)
EP (2) EP1809740B1 (cg-RX-API-DMAC7.html)
JP (3) JP5202953B2 (cg-RX-API-DMAC7.html)
CN (2) CN101437938B (cg-RX-API-DMAC7.html)
AU (1) AU2005304708B2 (cg-RX-API-DMAC7.html)
CA (1) CA2585980C (cg-RX-API-DMAC7.html)
WO (1) WO2006052925A2 (cg-RX-API-DMAC7.html)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20030376A1 (it) * 2003-07-31 2005-02-01 Univ Roma Procedimento per l'isolamento e l'espansione di cellule staminali cardiache da biopsia.
US11660317B2 (en) 2004-11-08 2023-05-30 The Johns Hopkins University Compositions comprising cardiosphere-derived cells for use in cell therapy
JP5265537B2 (ja) 2006-07-13 2013-08-14 セルアーティス アーベー ヒト胚盤胞由来幹細胞に由来する多能性心臓前駆細胞の新規の集団
EP2518140A1 (en) * 2006-11-09 2012-10-31 The Johns Hopkins University Dedifferentation of adult mammalian cardiomyocytes into cardiac stem cells
CA2705862C (en) * 2007-11-16 2018-03-27 San Diego State University Research Foundation Compositions and method for manipulating pim-1 activity in circulatory system cells
US20090227469A1 (en) * 2008-03-10 2009-09-10 Conklin Bruce R Cells and assays for use in detecting long qt syndrome
AU2010233169A1 (en) 2009-04-09 2011-11-03 Arizona Board Of Regents On Behalf Of The University Of Arizona Cellular seeding and co-culture of a three dimensional fibroblast construct
WO2010141877A1 (en) * 2009-06-04 2010-12-09 Cedars-Sinai Medical Center Method of treating stem cells
WO2011057249A2 (en) 2009-11-09 2011-05-12 The Brigham And Women's Hospital, Inc. Treatment of heart disease
US20120288481A1 (en) * 2009-11-09 2012-11-15 The Brigham And Women's Hospital, Inc. Treatment of heart disease
US9845457B2 (en) 2010-04-30 2017-12-19 Cedars-Sinai Medical Center Maintenance of genomic stability in cultured stem cells
US9249392B2 (en) 2010-04-30 2016-02-02 Cedars-Sinai Medical Center Methods and compositions for maintaining genomic stability in cultured stem cells
CN202078342U (zh) * 2011-04-02 2011-12-21 浙江海洋学院 外阴增生物活检钳
US20130142762A1 (en) 2011-11-07 2013-06-06 Hina W. Chaudhry Methods of cardiac repair
US11286463B2 (en) 2012-03-08 2022-03-29 Advanced ReGen Medical Technologies, LLC Reprogramming of aged adult stem cells
WO2013184527A1 (en) * 2012-06-05 2013-12-12 Capricor, Inc. Optimized methods for generation of cardiac stem cells from cardiac tissue and their use in cardiac therapy
WO2013184560A1 (en) * 2012-06-07 2013-12-12 Medrobotics Corporation Articulating surgical instruments and methods of deploying the same
EP3563859B1 (en) * 2012-08-13 2021-10-13 Cedars-Sinai Medical Center Cardiosphere-derived exosomes for tissue regeneration
GB201304831D0 (en) 2013-03-15 2013-05-01 Coretherapix Slu Adult cardiac stem cell population
KR101358777B1 (ko) * 2013-04-30 2014-02-10 서울대학교병원 심장내막 유래의 성체줄기세포 및 이의 제조방법
CN103431878B (zh) * 2013-09-05 2014-12-03 山东省农业科学院畜牧兽医研究所 一种动物组织取样器
WO2015081094A1 (en) 2013-11-27 2015-06-04 University Of Louisville Research Foundation, Inc. Cardiac progenitor cells and methods of use therefor
US20150174166A1 (en) 2013-12-20 2015-06-25 Advanced ReGen Medical Technologies, LLC Compositions for Cellular Restoration and Methods of Making and Using Same
US10772911B2 (en) 2013-12-20 2020-09-15 Advanced ReGen Medical Technologies, LLC Cell free compositions for cellular restoration and methods of making and using same
US20170296595A1 (en) 2014-09-18 2017-10-19 North Carolina State University Mammalian Lung Spheroids and Lung Spheroid Cells and Uses Thereof
CA2962444C (en) 2014-10-03 2023-09-05 Cedars-Sinai Medical Center Cardiosphere-derived cells and exosomes secreted by such cells in the treatment of muscular dystrophy
US20170296591A1 (en) * 2014-10-03 2017-10-19 Cedars-Sinai Medical Center Cardiosphere-derived cells (cdcs) as therapeutic agents for pulmonary hypertension
EP3402543B1 (en) 2016-01-11 2021-09-08 Cedars-Sinai Medical Center Cardiosphere-derived cells and exosomes secreted by such cells in the treatment of heart failure with preserved ejection fraction
US11534466B2 (en) 2016-03-09 2022-12-27 Aal Scientifics, Inc. Pancreatic stem cells and uses thereof
CN109475645A (zh) 2016-04-29 2019-03-15 先进瑞金医疗技术有限公司 微rna组合物及其制备和使用方法
US11351200B2 (en) 2016-06-03 2022-06-07 Cedars-Sinai Medical Center CDC-derived exosomes for treatment of ventricular tachyarrythmias
CN107460165A (zh) * 2016-08-10 2017-12-12 中山大学附属第医院 一种心脏干细胞及其用途
WO2018057542A1 (en) 2016-09-20 2018-03-29 Cedars-Sinai Medical Center Cardiosphere-derived cells and their extracellular vesicles to retard or reverse aging and age-related disorders
US20190365822A1 (en) * 2017-02-01 2019-12-05 Aal Scientifics, Inc. CARDIAC PROGENITOR CELLS HAVING ENHANCED p53 EXPRESSION AND USES THEREOF
WO2018186185A1 (ja) 2017-04-06 2018-10-11 日機装株式会社 細胞の培養方法、細胞支持複合体の製造方法、培養細胞及び細胞支持複合体
EP3612191B1 (en) 2017-04-19 2026-03-11 Cedars-Sinai Medical Center Methods and compositions for treating skeletal muscular dystrophy
KR102182513B1 (ko) * 2017-06-30 2020-11-25 인제대학교 산학협력단 인간 유래 심장 줄기세포 미세구의 제조 방법 및 용도
US20210085724A1 (en) 2017-08-04 2021-03-25 Cedars-Sinai Medical Center Cardiosphere-derived cells and their extracellular vesicles for treatment and prevention of cancer
US11660355B2 (en) 2017-12-20 2023-05-30 Cedars-Sinai Medical Center Engineered extracellular vesicles for enhanced tissue delivery
EP3740576A4 (en) 2018-01-18 2021-10-20 Advanced Regen Medical Technologies, LLC THERAPEUTIC COMPOSITIONS AND THEIR PREPARATION AND USE METHODS
EP3749344A4 (en) 2018-02-05 2022-01-26 Cedars-Sinai Medical Center METHODS OF THERAPEUTIC USE OF EXOSOMES AND Y-RNAS
CN108179133A (zh) * 2018-02-06 2018-06-19 广州大学 c-kit+心脏干细胞聚集体及分泌合成培养液在制备药物中应用
CN108379662A (zh) * 2018-02-08 2018-08-10 深圳大图科创技术开发有限公司 一种干细胞在心脏移植模型的应用
JP6978585B2 (ja) * 2018-03-22 2021-12-08 日機装株式会社 細胞の培養方法
CN109247958A (zh) * 2018-09-11 2019-01-22 凌宙贵 一种一次性经皮穿刺肺活检钳
AU2020267561A1 (en) * 2019-05-08 2021-12-23 Capricor, Inc. Therapeutically active cells and exosomes
CN110226946B (zh) * 2019-06-12 2022-05-17 杭州市第三人民医院 泌尿外科手术标本收集器
CN110448731A (zh) * 2019-07-23 2019-11-15 中国人民解放军总医院 温度敏感培养皿制备人心肌球源性干细胞膜性贴片的方法
CN110680411B (zh) * 2019-10-09 2020-10-02 山东大学 一种宫颈穿刺活检钳及其使用方法
CN110882015A (zh) * 2019-10-15 2020-03-17 张茹 一种可单人操作活检钳
WO2021241524A1 (ja) * 2020-05-25 2021-12-02 国立大学法人京都大学 増殖能が高い心筋細胞を選別する方法
CN115813456B (zh) * 2022-12-09 2023-06-27 沈阳医学院附属第二医院 一种心内膜心肌活组织钳及其使用方法
WO2026035943A1 (en) 2024-08-08 2026-02-12 Cedars-Sinai Medical Center Formulations for oral delivery of nucleic acids
WO2026035744A1 (en) 2024-08-08 2026-02-12 Cedars-Sinai Medical Center Combination therapies for metabolic disease

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5175004A (en) * 1988-12-27 1992-12-29 Matsumura Kenneth N Propagatable, new combinant cells for cellular replacement therapy
WO1999003973A1 (en) * 1997-07-14 1999-01-28 Osiris Therapeutics, Inc. Cardiac muscle regeneration using mesenchymal stem cells
EP1064356A2 (en) * 1998-03-23 2001-01-03 ZymoGenetics, Inc. Cardiac-derived stem cells
US6074408A (en) * 1998-10-13 2000-06-13 Freeman; Kenneth V. Modular medical instrument and method of using same
EP1254952A4 (en) * 1999-12-28 2004-09-22 Kyowa Hakko Kogyo Kk CELLS THAT ARE ABLE TO DIFFERENTIZE IN THE HEART MUSCLE CELLS
WO2002009650A2 (en) * 2000-07-31 2002-02-07 New York Medical College Methods and compositions for the repair and/or regeneration of damaged myocardium
US20030044976A1 (en) * 2001-08-27 2003-03-06 Advanced Cell Technology De-differentiation and re-differentiation of somatic cells and production of cells for cell therapies
TWI288779B (en) * 2002-03-28 2007-10-21 Blasticon Biotech Forschung Dedifferentiated, programmable stem cells of monocytic origin, and their production and use
WO2004009767A2 (en) * 2002-07-23 2004-01-29 Boston Scientific Limited Cell therapy for regeneration
WO2004044142A2 (en) * 2002-11-05 2004-05-27 The Brigham And Women's Hospital, Inc. Mesenchymal stem cells and methods of use thereof
US7837631B2 (en) * 2003-03-14 2010-11-23 Boston Scientific Scimed Inc. Biopsy forceps with removable jaw segments
ITRM20030376A1 (it) * 2003-07-31 2005-02-01 Univ Roma Procedimento per l'isolamento e l'espansione di cellule staminali cardiache da biopsia.
WO2005076743A2 (en) * 2004-02-17 2005-08-25 Yeda Research And Development Co. Ltd. Disaccharide molecules and derivatives thereof and methods of using same
ES2313805B1 (es) * 2004-10-04 2009-12-23 Cellerix, S.L. Identificacion y aislamiento de celulas multipotentes de tejido mesenquimal no osteocondral.
US8367405B2 (en) * 2005-04-12 2013-02-05 Mesoblast, Inc. Isolation of adult multipotential cells by tissue non-specific alkaline phosphatase
US20080089874A1 (en) * 2006-09-28 2008-04-17 The Regents Of The University Of California Directed differentiation and maturation of stem cell-derived cardiomyocytes
WO2008058216A2 (en) * 2006-11-07 2008-05-15 Keck Graduate Institute Enriched stem cell and progenitor cell populations, and methods of producing and using such populations
US20090081170A1 (en) * 2007-09-13 2009-03-26 Paul Riley Cardiac progenitor cells

Also Published As

Publication number Publication date
CN101087563A (zh) 2007-12-12
EP1809740A4 (en) 2009-11-25
JP2015180671A (ja) 2015-10-15
EP2546333A3 (en) 2013-04-10
JP2013046780A (ja) 2013-03-07
JP2008518730A (ja) 2008-06-05
EP1809740B1 (en) 2018-08-29
AU2005304708B2 (en) 2012-01-19
CA2585980C (en) 2017-09-26
AU2005304708A1 (en) 2006-05-18
CN101437938B (zh) 2015-05-13
US20100061966A1 (en) 2010-03-11
WO2006052925A2 (en) 2006-05-18
EP2546333A2 (en) 2013-01-16
JP6076402B2 (ja) 2017-02-08
US20080267921A1 (en) 2008-10-30
CA2585980A1 (en) 2006-05-18
WO2006052925A3 (en) 2009-05-14
EP1809740A2 (en) 2007-07-25
CN101437938A (zh) 2009-05-20
US20100068811A1 (en) 2010-03-18

Similar Documents

Publication Publication Date Title
JP6076402B2 (ja) 心臓幹細胞
Hou et al. Transplantation of mesenchymal stem cells from human bone marrow improves damaged heart function in rats
US20200016210A1 (en) Methods of Reducing Teratoma Formation During Allogeneic Stem Cell Therapy
WO2003093433A2 (en) Fibrin-based biomatrix
WO2006078034A1 (ja) 心筋細胞への分化能を有する細胞
Huang et al. Injectable cell constructs fabricated via culture on a thermoresponsive methylcellulose hydrogel system for the treatment of ischemic diseases
CN112292447B (zh) 脐带间充质干细胞及其细胞膜片的制备方法
WO2011058813A1 (ja) 心筋再生用細胞シート、製造方法及びその利用方法
EP2510956B1 (en) Adipocyte sheet, three-dimensional structure thereof, and method for producing the same
Khan et al. Combination of mesenchymal stem cells and three-dimensional collagen scaffold preserves ventricular remodeling in rat myocardial infarction model
Liu et al. Efficient isolation of cardiac stem cells from brown adipose
MX2012000493A (es) Celulas derivadas de tejido cardiaco.
KR20200047565A (ko) 어린 돼지 유래 줄기 세포 및 그 제조 방법
WO2011126264A2 (ko) 인간 줄기세포의 활성을 증가시키는 방법
AU2012202233B2 (en) Cardiac stem cells
JP2022550911A (ja) 軟骨形成ヒト間葉系幹細胞(msc)シート
Gillum et al. Adhesion proteins, stem cells, and arrhythmogenesis
Steele et al. Heart cells with regenerative potential from pediatric patients with end stage heart failure: a translatable method to enrich and propagate
JP4083024B2 (ja) 細胞移植方法及び試薬
Zhang et al. A novel population of human bone marrow multipotent mesenchymal stem cells regenerates infarcted myocardium in rats
JP2008141973A (ja) 心筋細胞の培養増殖法
Haraguchi et al. Cell-Based Therapy for Cardiovascular Injury
Lesman et al. Stem Cell-based Replacement Tissue for Heart Repair
IL193947A (en) Cells cultured as cd31brigi: it, a method for stimuli to differentiate into a congenital / precursor cell population (pcp), use of the same drug preparation population, and implantation device that includes it
van der Spoel et al. Human Cardiomyocyte Progenitor Cells Differentiate into Cardiomyocytes.

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20081107

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20081107

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110926

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20111220

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20111228

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120120

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120620

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20120914

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20120924

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20121017

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20130116

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20130213

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

Ref document number: 5202953

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20160222

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term